Concepedia

Marion de Jong

MD

Statistics

Publications

57

Citations

3.7K

H-Index

35

Active since

1991

Affiliations

Erasmus MC(Current)

Erasmus University Rotterdam

Rotterdam University of Applied Sciences

National Centre of Scientific Research "Demokritos"

Erasmus MC Cancer Institute

Marion de Jong is an author at Erasmus MC specializing in medicine, pharmacology, and radionuclide therapy.

Publications per year

1991–2023

57

Publications

57

Peptide receptor imaging and therapy.

D. J. Kwekkeboom, E. P. Krenning, Marion de Jong · PubMed · 2000 · 330 citations

Medicine, Nuclear Medicine, Radiology +17

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

Damian Wild, Jörg Schmitt, Mihaela Ginj et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 301 citations

Medicine, Endocrinology, Pharmacology +8

Radiolabelling DOTA-peptides with 68Ga

Wouter A.P. Breeman, Marion de Jong, Erik de Blois et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2005 · 292 citations

Medicine, Molecular Biology, Molecular Pharmaceutics +10

Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs.

Marion de Jong, Wout A. P. Breeman, Roelf Valkema et al. · PubMed · 2005 · 247 citations

Medicine, Nuclear Medicine, Oncology +17

Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results

Berthold A. Nock, Aikaterini Kaloudi, Emmanouil Lymperis et al. · Journal of Nuclear Medicine · 2016 · 167 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 57